GENOME RESEARCH LIMITED
A) TO ADVANCE RESEARCH INTO AND INVESTIGATION OF THE HUMAN GENOME AND TO PUBLISH THE USEFUL RESULTS OF SUCH RESEARCH B) TO ADVANCE SCIENTIFIC AND MEDICAL RESEARCH
Objects
A) TO ADVANCE RESEARCH INTO AND INVESTIGATION OF THE HUMAN GENOME AND TO PUBLISH THE USEFUL RESULTS OF SUCH RESEARCH B) TO ADVANCE SCIENTIFIC AND MEDICAL RESEARCH
Financial health, per its FY2025 accounts
The accounts state that the charity reported total income of £180.3 million and total expenditure of £183.5 million, resulting in a net expenditure of £2.7 million for the year. However, total net assets increased to £273.7 million, largely driven by a significant pension surplus of £108.2 million and other recognised gains. The trustees confirm that the charity is in a strong financial position with sufficient unrestricted reserves and ongoing funding support from its parent, Wellcome, to continue as a going concern.
What the accounts disclose
“£290,000 to £299,999 1 1”
“Income for the year totalled £180.3 million (2024: £177.3 million) of which 74% (2024: 72%) was provided by Wellcome.”
“As at 30 September 2025, Genome Research Trading Limited, GRL Construction Limited and Base RX Limited were 100% subsidiaries of GRL.”
Year-over-year changes
- Top pay band moved from £360,000 - £369,999 (FY2024) to £290,000 to £299,999 (FY2025).
Policies the charity declares
- Bullying and harassment policy and procedures
- Complaints policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Paying staff
- Risk management
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 30/09/2025
- Government income: £2,015,983 — grants £2,015,983 (16); 1% of the £180,349,000 total gross income on the same return
- Employees paid over £60,000: 284 (£60,001–£70,000: 136; £70,001–£80,000: 60; £80,001–£90,000: 27; £90,001–£100,000: 16; £100,001–£110,000: 14; £110,001–£120,000: 8; £120,001–£130,000: 3; £130,001–£140,000: 6; £140,001–£150,000: 1; £150,001–£200,000: 11; £250,001–£300,000: 2)
- Trustee benefits, answered Yes to: any trustee benefit; payments to trustees for services to the charity
- Has a trading subsidiary
Self-declared on the annual return for the financial year ending 30/09/2024
- Government income: £1,666,214 — grants £1,666,214 (15); under 1% of the £177,347,000 total gross income on the same return
- Employees paid over £60,000: 298 (£60,001–£70,000: 143; £70,001–£80,000: 67; £80,001–£90,000: 26; £90,001–£100,000: 16; £100,001–£110,000: 13; £110,001–£120,000: 10; £120,001–£130,000: 3; £130,001–£140,000: 5; £140,001–£150,000: 2; £150,001–£200,000: 10; £250,001–£300,000: 3)
- Trustee benefits, answered Yes to: any trustee benefit; payments to trustees for services to the charity
- Has a trading subsidiary
Self-declared on the annual return for the financial year ending 30/09/2023
- Government income: £21,732,222 — contracts £20,666,557 (1), grants £1,065,665 (24); 11% of the £189,031,000 total gross income on the same return
- Employees paid over £60,000: 240 (£60,001–£70,000: 119; £70,001–£80,000: 41; £80,001–£90,000: 25; £90,001–£100,000: 19; £100,001–£110,000: 11; £110,001–£120,000: 4; £120,001–£130,000: 4; £130,001–£140,000: 3; £150,001–£200,000: 9; £200,001–£250,000: 3; £250,001–£300,000: 1; £350,001–£400,000: 1)
- Trustee benefits, answered Yes to: any trustee benefit; payments to trustees for services to the charity
- Has a trading subsidiary
In the news
Funders the charity credits
- Wellcome
UK research funding (UKRI Gateway to Research)
- Cambridge Autonomous Bus System Feasibility Study
- High-speed single molecule detection combining short DNA probes and barcoding bioinformatics for use as a new broad spectrum point-of-care diagnostic
- Personalised iPS Cell Culture System
Property (HM Land Registry)
Structured financials (annual return, FY ending 30/09/2025)
Trustees
- Dr John-Arne Rottingenchair
- Caroline Relton
- Daniel Abrams
- Dr Nicole Mather
- Karen Chadwick
- Mark McCarthy
- Matthew Newcombe-Ellis
- Michael Dunn
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/09/2025 | £180.3m | £183.5m |
| 30/09/2024 | £177.3m | £183.5m |
| 30/09/2023 | £189.0m | £184.0m |
| 30/09/2022 | £185.9m | £183.2m |
| 30/09/2021 | £221.5m | £207.9m |
Common questions
Is GENOME RESEARCH LIMITED financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported total income of £180.3 million and total expenditure of £183.5 million, resulting in a net expenditure of £2.7 million for the year. However, total net assets increased to £273.7 million, largely driven by a significant pension surplus of £108.2 million and other recognised gains. The trustees confirm that the charity is in a strong financial position with sufficient unrestricted reserves and ongoing funding support from its parent, Wellcome, to continue as a going concern. Its FY2025 accounts were audited by Deloitte LLP.
What does the highest-paid employee of GENOME RESEARCH LIMITED earn?
Per its FY2025 accounts, the highest-paid employee was in the £290,000 to £299,999 band.
Who funds GENOME RESEARCH LIMITED?
Funders whose own accounts filings name GENOME RESEARCH LIMITED as a grant recipient include HEALTH DATA RESEARCH UK, THE KENNEL CLUB CHARITABLE TRUST.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| HEALTH DATA RESEARCH UK | FY2023 | £2.2m | HDR UK Cambridge Substantive Site |
| ALZHEIMER'S RESEARCH UK | FY2025 | Unverified read£69k | |
| THE KENNEL CLUB CHARITABLE TRUST | FY2024 | £65k | Education and other grants |
| THE KENNEL CLUB CHARITABLE TRUST | FY2023 | £40k | Education and other grants |
| THE KENNEL CLUB CHARITABLE TRUST | FY2022 | £15k | Education and other grants |
Government & lottery funding
| Funder | Date | Amount | Purpose |
|---|---|---|---|
| UK government | — | £24k | Identification and curation of proteins and pathways involved in immune system regulation |
| UK government | — | £24k | Next Generation sequencing of barcoded plasmodium falciparum mutants to dissect parasite fitness costs associated with drug resistance |
| UK government | — | £59k | Wormbase ParaSite |
| UK government | — | £83k | Predicting cell-cell horizontal transmission of antibiotics resistance from genome and phenome |
| UK government | — | £87k | Deciphering the effects of genetic variability in regulatory T cells - links with autoimmunity |
| UK government | — | £109k | JPND Genomic Instability in Alzheimer's Disease and Related Disorders: a Single-Cell Approach |
| UK government | — | £130k | Prevention and Restriction of Antimicrobial Resistance in Pneumococci by Multi-Level Modelling |
| UK government | — | £200k | The identification of genetic vulnerabilities in head and neck cancers for the development of novel therapies. |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| WELLCOME TRUST | 1 | £30.1m |
| Bird Song Trust | 1 | £203k |
| THE BATCHWORTH TRUST | 1 | £5k |
| DR RADCLIFFE'S TRUST | 1 | £5k |
| THE TANLAW FOUNDATION | 1 | £3k |
| THE MCBAIN FAMILY FOUNDATION | 1 | £2k |
| THE ASTOR FOUNDATION | 1 | £2k |
| THE OAKDALE TRUST | 1 | £2k |
Charities like this
- CANCER RESEARCH AND GENETICS UK
- MEDICAL RESEARCH FOUNDATION
- THE ASSOCIATION FOR CLINICAL GENOMIC SCIENCE
- SOCIETY OF GENEALOGISTS
- THE GEN FOUNDATION
- BRITISH SOCIETY FOR GENETIC MEDICINE
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| GENOME RESEARCH LIMITED | £180.3m | £290,000 to £299,999 | — | unclear | — | no doubt |
| CANCER RESEARCH AND GENETICS UK | £128k | — | 0 | unclear | — | no doubt |
| MEDICAL RESEARCH FOUNDATION | £3.7m | — | — | unclear | — | no doubt |
| THE ASSOCIATION FOR CLINICAL GENOMIC SCIENCE | £57k | — | 0 | above | — | no doubt |
| SOCIETY OF GENEALOGISTS | £768k | — | — | above | — | no doubt |
| THE GEN FOUNDATION | £32k | — | — | unclear | — | no doubt |